# ANDA Asset Management

> ANDA Asset Management is a VC fund in Gangneung backing Energy, Battery and Medical. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Gangneung, South Korea
- Total investments: 3
- Last investment: Jul 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/andaasset/
- Website: http://www.andaasset.com/

ANDA Asset Management is a VC fund in Gangneung focused on Energy and Battery. ANDA Asset Management offers investment management and advisory services.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Energy | 1 | 33% |
| Battery | 1 | 33% |
| Medical | 1 | 33% |
| Power Grid | 1 | 33% |
| Health Care | 1 | 33% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series D | 1 | 33% |
| Post-IPO Equity | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Namyangju Maseok IDC | Namyangju Maseok IDC is a Special Purpose Company established to develop and operate a massive commercial Artificial Intelligence (AI) data center. | $20.5M | Seed | Jul 24, 2026 |  |
| ROKIT Healthcare | ROKIT Healthcare provides hardware, software, and application support. Their custom fabrication technologies deliver solutions to the design, creation, and applications of three-dimensional systems. They provide suffering patients and humans with a hyper-personalized medical organ regeneration solution. They apply artificial intelligence and 3dbioprinting technology to regenerate the skin and cartilage organs through surgery for patients. | $42.5M | Post-IPO Equity | Mar 10, 2026 |  |
| 1st Biotherapeutics | 1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients. We are focused on discovery and development of innovative first-in-class therapeutic candidates with highly likelihood of clinical success. 1STBIO currently has 24 employees with expertise in biochemistry, medicinal chemistry,pharmacology, and business development. We are working as a core expertise team of drug discovery/development and are rigorously connected to R&D networking of academia, hospitals, industry, CRO’s and investors in Korea, China and US. Our ultimate goal is to use our experience and knowledge to discover and develop effective molecular therapeutics for patients. | $21.9M | Series D | Jan 26, 2026 |  |

3 of 3 investments shown.

## Co-investors
- [ASEM Asset Management](https://shizune.co/investors/profile/asem-asset-management) — VC Fund, 1 deal together
- [CKD Venture Capital Corporation](https://shizune.co/investors/profile/ckd-venture-capital-corporation) — VC Fund, 1 deal together
- [Dayli Partners](https://shizune.co/investors/profile/dayli-partners) — VC Fund, 1 deal together
- [Eugene Asset Management](https://shizune.co/investors/profile/eugene-asset-management) — VC Fund, 1 deal together
- [FND Partners](https://shizune.co/investors/profile/fnd-partners) — VC Fund, 1 deal together
- [Gurum Investment-Double Capital](https://shizune.co/investors/profile/gurum-investment-double-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does ANDA Asset Management invest in?

ANDA Asset Management invests primarily in Energy, Battery and Medical startups, most often at Seed and Series D stage. Most of the 3 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ANDA Asset Management last invest?

The most recent investment recorded for ANDA Asset Management closed in Jul 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co